Stockreport

Lilly snaps up Ventyx for $1.2B in pursuit of oral immune drugs [Yahoo! Finance]

Ventyx Biosciences, Inc.  (VTYX) 
PDF Eli Lilly is deepening its investment in inflammatory diseases, spending $1.2 billion to buy Ventyx Biosciences for an experimental drug that has the potential to treat [Read more]